ARS Pharmaceuticals, Inc.
SPRY
$9.72
-$0.08-0.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.78% | 23.29% | 37.51% | -15.33% | -13.27% |
| Total Receivables | 4,712.18% | 1,562.46% | 1,235.57% | 52.21% | -43.66% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 366.91% | 734.87% | 130.13% | -26.34% | -48.77% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 307.85% | 14.92% | 88.96% | -- | -- |
| Total Current Assets | 27.50% | 34.31% | 44.26% | -14.59% | -13.45% |
|
|
|||||
| Total Current Assets | 27.50% | 34.31% | 44.26% | -14.59% | -13.45% |
| Net Property, Plant & Equipment | 237.47% | 40.91% | 29.37% | 1.96% | -17.07% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 1,145.54% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3,540.58% | 2,706.63% | 38,504.76% | -- | -83.93% |
| Total Assets | 41.23% | 43.82% | 50.59% | -12.45% | -14.22% |
|
|
|||||
| Total Accounts Payable | 391.99% | 891.66% | 1,761.00% | 179.03% | 117.99% |
| Total Accrued Expenses | 248.00% | 322.75% | 1,061.90% | 3.19% | -61.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 268.13% | -66.36% | -82.28% | -56.60% | -31.33% |
| Total Finance Division Other Current Liabilities | 8,039.29% | 4,038.14% | 393.74% | 4.16% | -19.42% |
| Total Other Current Liabilities | 8,039.29% | 4,038.14% | 393.74% | 4.16% | -19.42% |
| Total Current Liabilities | 578.05% | 643.53% | 880.34% | 48.69% | -33.11% |
|
|
|||||
| Total Current Liabilities | 578.05% | 643.53% | 880.34% | 48.69% | -33.11% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1,701.50% | 2,547.21% | 3,786.12% | 47.47% | -34.07% |
|
|
|||||
| Common Stock & APIC | 6.77% | 5.62% | 4.94% | 3.40% | 3.21% |
| Retained Earnings | -31.16% | -11.05% | 6.09% | -39.56% | -41.04% |
| Treasury Stock & Other | 68.28% | 158.06% | 348.98% | 310.56% | 19.44% |
| Total Common Equity | -10.65% | 2.28% | 11.28% | -15.30% | -13.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.65% | 2.28% | 11.28% | -15.30% | -13.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.65% | 2.28% | 11.28% | -15.30% | -13.40% |
|
|
|||||